- Home
- CHR vs AZTR Comparison
CHR vs AZTR Comparison
Compare CHR & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- AZTR
- Stock Information
- Founded
- CHR 2016
- AZTR 2014
- Country
- CHR China
- AZTR United States
- Employees
- CHR N/A
- AZTR N/A
- Industry
- CHR EDP Services
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- AZTR Health Care
- Exchange
- CHR Nasdaq
- AZTR Nasdaq
- Market Cap
- CHR 4.3M
- AZTR 4.2M
- IPO Year
- CHR N/A
- AZTR 2023
- Fundamental
- Price
- CHR $0.05
- AZTR $0.34
- Analyst Decision
- CHR
- AZTR Strong Buy
- Analyst Count
- CHR 0
- AZTR 1
- Target Price
- CHR N/A
- AZTR $4.00
- AVG Volume (30 Days)
- CHR 93.9M
- AZTR 2.8M
- Earning Date
- CHR 07-30-2025
- AZTR 11-12-2025
- Dividend Yield
- CHR N/A
- AZTR N/A
- EPS Growth
- CHR N/A
- AZTR N/A
- EPS
- CHR 1.92
- AZTR N/A
- Revenue
- CHR $147,134,000.00
- AZTR N/A
- Revenue This Year
- CHR N/A
- AZTR N/A
- Revenue Next Year
- CHR N/A
- AZTR N/A
- P/E Ratio
- CHR $0.02
- AZTR N/A
- Revenue Growth
- CHR N/A
- AZTR N/A
- 52 Week Low
- CHR $0.04
- AZTR $0.32
- 52 Week High
- CHR $3.45
- AZTR $4.33
- Technical
- Relative Strength Index (RSI)
- CHR 21.81
- AZTR 29.98
- Support Level
- CHR $0.04
- AZTR $0.32
- Resistance Level
- CHR $0.05
- AZTR $0.43
- Average True Range (ATR)
- CHR 0.03
- AZTR 0.07
- MACD
- CHR 0.02
- AZTR -0.01
- Stochastic Oscillator
- CHR 2.08
- AZTR 3.02
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.